← FDA Drug Approvals (Drugs@FDA)

LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE

NDA · New Drug Application · Sponsor: HETERO LABS UNIT III · Approved 2011-11-18

Drug application

FDA Application #

NDA202157

Application type

New Drug Application

Brand name

LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE

Generic name

Lamivudine

Active ingredients

LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

HETERO LABS UNIT III

First approval

2011-11-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown